AAAAAA

   
Results: 1-13 |
Results: 13

Authors: May, F Hartung, R Breul, J
Citation: F. May et al., The ability of the American Joint Committee On Cancer Staging system to predict progression-free survival after radical prostatectomy, BJU INT, 88(7), 2001, pp. 702-707

Authors: May, F Treumann, T Dettmar, P Hartung, R Breul, J
Citation: F. May et al., Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer, BJU INT, 87(1), 2001, pp. 66-69

Authors: Brill, T Barba, M Breul, J Gansbacher, B
Citation: T. Brill et al., Gene therapy for prostatic cancer, INTERNIST, 42(10), 2001, pp. 1328

Authors: Paul, R Alschibaja, M von Randenborgh, H Hartung, R Breul, J
Citation: R. Paul et al., Neoadjuvant hormonal therapy for localized prostate cancer prior to curative radical prostatectomy - Advantage or disadvantage?, AKT UROL, 32(4), 2001, pp. 165-172

Authors: van Randenborgh, H Breul, J Leyh, H Hartung, R
Citation: H. Van Randenborgh et al., Urinary continence and positive margins in radical retropubic prostatectomy after preparation of an intraprostatic urethral stump, AKT UROL, 32(2), 2001, pp. 84-86

Authors: Paul, R Bottermann, P Breul, J Hartung, R
Citation: R. Paul et al., Isoenzymes of alkaline phosphatase - Useful parameters for identification of bone metastasis in prostatic carcinoma?, ONKOLOGIE, 23(1), 2000, pp. 42-46

Authors: Hofer, C Hartung, R Gobel, R Deering, P Lehmer, A Breul, J
Citation: C. Hofer et al., New ultradeformable drug carriers for potential transdermal application ofinterleukin-2 and interferon-alpha: Theoretic add practical aspects, WORLD J SUR, 24(10), 2000, pp. 1187-1189

Authors: Paul, R Breul, J
Citation: R. Paul et J. Breul, Antiandrogen withdrawal syndrome associated with prostate cancer therapies- Incidence and clinical significance, DRUG SAFETY, 23(5), 2000, pp. 381-390

Authors: Hofer, C Sauerstein, P Wolter, C Scholz, M Hartung, R Breul, J
Citation: C. Hofer et al., Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist, UROL INTERN, 64(1), 2000, pp. 18-23

Authors: Avril, N Weber, W Breul, J
Citation: N. Avril et al., Prostate cancer, PET IN CLINICAL ONCOLOGY, 2000, pp. 287-298

Authors: Hofer, C Laubenbacher, C Block, T Breul, J Hartung, R Schwaiger, M
Citation: C. Hofer et al., Fluorine-18-fluorodeoxyglucose positron emission tomography is useless forthe detection of local recurrence after radical prostatectomy, EUR UROL, 36(1), 1999, pp. 31-35

Authors: Hofer, C Gobel, R Deering, P Lehmer, A Breul, J
Citation: C. Hofer et al., Formulation of interleukin-2 and interferon-alpha containing ultradeformable carriers for potential transdermal application, ANTICANC R, 19(2C), 1999, pp. 1505-1507

Authors: Kropfl, D Scharpertons, T Verweyen, A Breul, J Goepel, M
Citation: D. Kropfl et al., Reconstruction of panurethral strictures of the urethra with fascio-cutaneous skin flaps, AKT UROL, 30(1), 1999, pp. 10-19
Risultati: 1-13 |